用基因表达谱芯片筛选老年痴呆异常表达基因及针刺对其主效基因的影响
|
摘要
老年性痴呆是多基因协同(拮抗)作用的生命过程，发病率逐年上升，尚未找到确切病因。本研究利用小鼠基因表达谱芯片，应用AD替代研究模型SAM，筛选老年痴呆异常表达基因，探讨其在老年痴呆病生理机制中的作用；用Northern杂交研究周期蛋白依赖性蛋白激酶抑制因子P15和钙调神经磷酸酶CaN mRNA表达水平的增龄性变化，了解不同针刺穴区对其表达的影响。
得到如下主要结论：
1．选择2月龄SAMP8作10月龄SAMP8的实验对照组，筛选到差异表达基因234个，其中下调表达的基因有146个，59个基因能在GenBank中登陆；上调表达的基因有88个，87个基因能在GenBank中登陆。
2．选择10月龄SAMR1作10月龄SAMP8的实验对照组，筛选到差异表达基因有242个，其中下调表达的基因有173个，62个基因能在GenBank中登陆；上调表达的基因有69个，68个基因能在GenBank中登陆。
3．选择2月龄SAMP8和10月龄SAMR1同时作10月龄SAMP8的实验对照组，筛选到差异表达基因110个，其中下调表达的基因有79个，30个基因能在GenBank中登陆；上调表达的基因有31个，并全部能在GenBank中登陆。下调涉及突触囊泡释放、信号传导、细胞骨架、能量代谢等；上调涉及细胞周期，离子通道，蛋白质合成，炎症反应等病生理功能。
4．与主导衰老的P16属同一家族基因，P15 mRNA的表达上调使细胞周期调控异常，推测P15可能是导致老年性痴呆的重要因素；CaN基因表达下调，改变了蛋白磷酸化和去磷酸化的动态平衡，由此可能影响信号传导、基因转录等重要的细胞功能活动和加速NFT的形成，从而促进老年痴呆的发生发展。
5．进一步用Northern杂交研究SAMP10脑P15 mRNA的增龄性变化，发现其在6月龄开始表达上调。两针刺组均有下调8月龄SAMP10脑P15 mRNA表达的趋势，其中滋补肝肾组下调P15 mRNA表达的作用有优于醒脑组的趋势。针刺可能通过抑制P15 mRNA的表达，增强DNA损伤修复能力，减少细胞凋亡，延缓衰老速度。
6．用Northern杂交研究SAMP10脑CaN mRNA的增龄性变化，CaN mRNA在6月龄时表达水平最低。两针刺组均有上调8月龄SAMP10脑CaN mRNA表达的趋势。其中醒脑组上调CaN mRNA表达的作用有优于滋补肝肾组的趋势。针刺可能通过增强CaN mRNA的表达，改善了蛋白磷酸化-去磷酸化的平衡状态和水平，影响离子通道
天津中医学院博士研究生毕业(学位)论文
中文摘要
开关的调控，调节基因转录水平，减少NHF的形成，稳定微管结构。不同针刺穴区对
不同基因的调整作用不同。
Senile dementia is a life process with multiple genes cooperated (antagonistic) actions. Its incidence is increasing rapidly. The definitive etiological factors are not known up to now. In this study, the mice gene expression profiling is used to screen the genes that are abnormally expressed in the senescence-accelerated-mice (SAM) brain samples, which are regarded as a replacing animal model for studying Alzheimer's disease. The roles of some genes abnormally expressed in the pathological and physiological mechanisms of senile dementia are also discussed. The mRNA expression changes of two genes, cyclin dependent kinase inhibitor 2b (P15) and calcineurin (CaN), with aging in the SAMP 10 were observed by Northern hybridization. The effects of acupuncture playing in different acupoint regions onto the expression levels of the two genes are investigated. The main results are below:
1. The 2-month-old SAMP8 is selected as a control group compared with a 10-month-old SAMPS. We screen out 234 genes that are abnormally expressed, among which 146 genes are down-regulated and 88 genes are up-regulated. Among those down-regulated genes, 87 genes are logging in GenBank while among those up-regulated, 59 genes are logging in GenBank.
2. The 10-month-old SAMR1 is selected as a control group compared with the 10-month-old SAMPS. We screen out 242 genes are abnormally expressed, among which 173 genes are down-regulated (among which 62 genes are logging in GenBank), while 69 genes are up-regulated (among which 68 genes are logging in GenBank).
3. The 2-month-old SAMP8 and a/the 10-month-old SAMR1 are both selected as control groups compared with the 10-month-old SAMP8. We screen out 110 genes that are abnormally expressed, among which 79 genes are down-regulated (among which 30 genes are logging in GenBank), while 31 genes are up-regulated, and all are logging in GenBank. The down-regulated genes are mostly related to the pathological functions of releasing of synaptic vesicle, signal transduction, cell skeleton, energy metabolism, etc. On the other hand, the up-regulated genes are mainly involved in the pathology functions of cell cycle, ion channel, protein synthesis, inflammatory reaction, and so on.
4. As a member of the same family with P16, which has been demonstrated as a major gene of
aging, the up-regulated expression of P15 mRNA disorders the modulation of cell cycle. This suggests that P15 could be a crucial factor leading to senile dementia. The
down-regulation of CaN mRNA might break the dynamic balance of protein phosphorylation and dephosphorylation, through which CaN accelerates the formation of NHF and affects cells' normal functions such as signal transduction and gene transcription. So it's suspected that CaN might activate the occurrence and accelerate the development of senile dementia.
5. Northern hybridization is used to study the changes of P1 5 mRNA with aging in the brain of SAMP 10. It is detected that the expression of P15 mRNA is up-regulated from the beginning of 6-month-old. Both acupuncture groups have the capacity of helping to down-regulate the abnormal expression of P15 mRNA in 8-month-old SAMP 10. The down-regulation role of ZBGS on P15 mRNA seems to be stronger than that of XNKQ. By depressing the expression of P15 mRNA, acupuncture might have the capacity of repairing the damaged DNA, lessening the cell apoptosis and delaying the speed of aging..
6. By using Northern hybridization, the changes of CaN mRNA with aging is studied in the brain of SAMP 10. The expression level of CaN mRNA is the lowest at 6-month-old sample. Both acupuncture groups have the capacity of helping to up-regulate the abnormal expression of CaN mRNA in 8-month-old SAMP 10. The up-regulation role of XNKQ on CaN seems to be stronger than that of ZBGS. By elevating the expression of CaN mRNA. acupuncture might have improved the state and the level of balance that of phosphorylation and dephosphorylation, influenced the switching modulation of the ion channel, reg
得到如下主要结论：
1．选择2月龄SAMP8作10月龄SAMP8的实验对照组，筛选到差异表达基因234个，其中下调表达的基因有146个，59个基因能在GenBank中登陆；上调表达的基因有88个，87个基因能在GenBank中登陆。
2．选择10月龄SAMR1作10月龄SAMP8的实验对照组，筛选到差异表达基因有242个，其中下调表达的基因有173个，62个基因能在GenBank中登陆；上调表达的基因有69个，68个基因能在GenBank中登陆。
3．选择2月龄SAMP8和10月龄SAMR1同时作10月龄SAMP8的实验对照组，筛选到差异表达基因110个，其中下调表达的基因有79个，30个基因能在GenBank中登陆；上调表达的基因有31个，并全部能在GenBank中登陆。下调涉及突触囊泡释放、信号传导、细胞骨架、能量代谢等；上调涉及细胞周期，离子通道，蛋白质合成，炎症反应等病生理功能。
4．与主导衰老的P16属同一家族基因，P15 mRNA的表达上调使细胞周期调控异常，推测P15可能是导致老年性痴呆的重要因素；CaN基因表达下调，改变了蛋白磷酸化和去磷酸化的动态平衡，由此可能影响信号传导、基因转录等重要的细胞功能活动和加速NFT的形成，从而促进老年痴呆的发生发展。
5．进一步用Northern杂交研究SAMP10脑P15 mRNA的增龄性变化，发现其在6月龄开始表达上调。两针刺组均有下调8月龄SAMP10脑P15 mRNA表达的趋势，其中滋补肝肾组下调P15 mRNA表达的作用有优于醒脑组的趋势。针刺可能通过抑制P15 mRNA的表达，增强DNA损伤修复能力，减少细胞凋亡，延缓衰老速度。
6．用Northern杂交研究SAMP10脑CaN mRNA的增龄性变化，CaN mRNA在6月龄时表达水平最低。两针刺组均有上调8月龄SAMP10脑CaN mRNA表达的趋势。其中醒脑组上调CaN mRNA表达的作用有优于滋补肝肾组的趋势。针刺可能通过增强CaN mRNA的表达，改善了蛋白磷酸化-去磷酸化的平衡状态和水平，影响离子通道
天津中医学院博士研究生毕业(学位)论文
中文摘要
开关的调控，调节基因转录水平，减少NHF的形成，稳定微管结构。不同针刺穴区对
不同基因的调整作用不同。
Senile dementia is a life process with multiple genes cooperated (antagonistic) actions. Its incidence is increasing rapidly. The definitive etiological factors are not known up to now. In this study, the mice gene expression profiling is used to screen the genes that are abnormally expressed in the senescence-accelerated-mice (SAM) brain samples, which are regarded as a replacing animal model for studying Alzheimer's disease. The roles of some genes abnormally expressed in the pathological and physiological mechanisms of senile dementia are also discussed. The mRNA expression changes of two genes, cyclin dependent kinase inhibitor 2b (P15) and calcineurin (CaN), with aging in the SAMP 10 were observed by Northern hybridization. The effects of acupuncture playing in different acupoint regions onto the expression levels of the two genes are investigated. The main results are below:
1. The 2-month-old SAMP8 is selected as a control group compared with a 10-month-old SAMPS. We screen out 234 genes that are abnormally expressed, among which 146 genes are down-regulated and 88 genes are up-regulated. Among those down-regulated genes, 87 genes are logging in GenBank while among those up-regulated, 59 genes are logging in GenBank.
2. The 10-month-old SAMR1 is selected as a control group compared with the 10-month-old SAMPS. We screen out 242 genes are abnormally expressed, among which 173 genes are down-regulated (among which 62 genes are logging in GenBank), while 69 genes are up-regulated (among which 68 genes are logging in GenBank).
3. The 2-month-old SAMP8 and a/the 10-month-old SAMR1 are both selected as control groups compared with the 10-month-old SAMP8. We screen out 110 genes that are abnormally expressed, among which 79 genes are down-regulated (among which 30 genes are logging in GenBank), while 31 genes are up-regulated, and all are logging in GenBank. The down-regulated genes are mostly related to the pathological functions of releasing of synaptic vesicle, signal transduction, cell skeleton, energy metabolism, etc. On the other hand, the up-regulated genes are mainly involved in the pathology functions of cell cycle, ion channel, protein synthesis, inflammatory reaction, and so on.
4. As a member of the same family with P16, which has been demonstrated as a major gene of
aging, the up-regulated expression of P15 mRNA disorders the modulation of cell cycle. This suggests that P15 could be a crucial factor leading to senile dementia. The
down-regulation of CaN mRNA might break the dynamic balance of protein phosphorylation and dephosphorylation, through which CaN accelerates the formation of NHF and affects cells' normal functions such as signal transduction and gene transcription. So it's suspected that CaN might activate the occurrence and accelerate the development of senile dementia.
5. Northern hybridization is used to study the changes of P1 5 mRNA with aging in the brain of SAMP 10. It is detected that the expression of P15 mRNA is up-regulated from the beginning of 6-month-old. Both acupuncture groups have the capacity of helping to down-regulate the abnormal expression of P15 mRNA in 8-month-old SAMP 10. The down-regulation role of ZBGS on P15 mRNA seems to be stronger than that of XNKQ. By depressing the expression of P15 mRNA, acupuncture might have the capacity of repairing the damaged DNA, lessening the cell apoptosis and delaying the speed of aging..
6. By using Northern hybridization, the changes of CaN mRNA with aging is studied in the brain of SAMP 10. The expression level of CaN mRNA is the lowest at 6-month-old sample. Both acupuncture groups have the capacity of helping to up-regulate the abnormal expression of CaN mRNA in 8-month-old SAMP 10. The up-regulation role of XNKQ on CaN seems to be stronger than that of ZBGS. By elevating the expression of CaN mRNA. acupuncture might have improved the state and the level of balance that of phosphorylation and dephosphorylation, influenced the switching modulation of the ion channel, reg
引文
1． Aihara Y, Kurabayashi M, et al. Cardiac ankyrin repeat protein is a novel marker of cardiac hypertrophy: role of M-CAT element within the promoter[J]. Hypertension, 2000 , 36(1) : 48-53
2． Alonso AC, Grundke H, Iqbal K. Alzheimer's disease hyperphosphorylated tau sequesters normal tau into tangles of filaments and disassembles microtubules[J]. Nature Med, 1996． 2:783-785
3． Arendt T, Holzer M, et al. Paired helical filament-like phosphorylation of tau, deposition of beta/A4-amyloid and memory impairment in rat induced by chronic inhibition of phosphatase 1 and 2A[J]. Neuroscience 1995; 69(3) :691-698
4． Arendt T, Rodel L, Gartner U, Holzer M. Expression of the cyclin-dependent kinase inhibitor p16 in Alzheimer's disease[J]. Neuroreport .1996, 7(18) : 3047-3049 Arendt T, Holzer M, Gartner U. Neuronal expression of cycline dependent kinase inhibitors of the INK4 family in Alzheimer's disease[J]. J Neural Transm 1998; 105 (8-9) : 949-960
6． Arendt T. Dysregulation of neuronal differentiation and cell cycle control in Alzheimer's disease[J]. J Neural Transm Suppl. 2002, (62) : 77-85
7． Argiles JM, Busquets S.et al.The role of uncoupling proteins in pathophysiological states [J]. Biochem Biophys Res Commun. 2002, 293 (4) : 1145-1152
8． Andrea LeBlanc, Hui Liu. Caspase-6 Role in Apoptosis of Human Neurons, Amyloidogenesis, and Alzheimer's Disease[J]. J Biol Chem, 1999, 274: 23426-23436
9． Barria A, Muller D, et al. Regulatory phosphorylation of AMPA-type glutamate receptors by CaMK-Ⅱ during long-term potentiation[J]. Science, 1997, 276:2042-2045
10． Liu Q, Berg DK. Actin filament and the opposing actions of CaM kinase and calcineurin in regulating α7-containing nicotine receptors on chick ciliary ganglion neurons[J]. J Neurosci. 1999, 19:10280-10289
11． Bertoni-Freddaei C, Giuli C. et al. Quantitative investigation of the morphological plasticity of synaptic junction in rat dentate gyrus during aging[J]. Brain Res. 1986． 366:
187-192
12． Bertoni-Freddari C, Fattoretti P, et al. Morphological adaptive response of the synaptic junction zones in the human dentate gyrus during aging and Alzheimer's disease[J]. Brain Res. 1990, 517:69-75
13． Bikelenbom P. Zhan S S. et al. Inflammatory mechanisms in Alzheimer's disease [J]. Trends in Pharmacological Sciences. 1994, 15: 447-450
14． Bouras C, Hof PR,et al. Regional distributeon of neurofibrillary tangles and senile plaques in the cerebral cortex of elderly patients: a quantitative ebaluation of a one-year autopsy population from a geriatric hoxpital. Cereb Cortex. 1994,4, 138-150
15． Bouvier-Labit C, Civatte M, Figarella-Branger D.et al.p16INK4a and p19INK4d mRNA expression in neuroglial tumours: correlation with Ki67 proliferation index[J]. Neuropathol Appl Neurobiol. 1999,25(5) :408-416
16． Braak H. Braak E.Evaluation of the neuroupathology of Alzheimer's diseaee[J]. Acta Neurologica Scand. 1996, 93(Suppl): 3-9
17． Buee L, Hof PR, et al. Brain microvascular changes in Alzheimer's disease and other dementias[J]. Ann NY Acad Sci. 1997; 826: 7-24
18． Burton T, Liang B,et al.Transcriptional activation and increase in expression of Alzheimer's beta-amyloid precursor protein gene is mediated by TGF-beta in normal human astrocytes[J]. Biochem Biophys Res Commun. 2002, 295 (3) : 702-712
19． Busser J, Geldmacher DS, Herrup K. Ectopic cell cycle proteins predict the sites of neuronal cell death in Alzheimer's disease brain[J]. J Neurosci . 1998 ,15;18 (8) : 2801-2807
20． Charlws J. Sherr. Cancer cell cycles [J]. Science. 1996, 274(5293) : 1672-1677
21． Chee M, Yang R, et al. Accessing genetic information with high-density DNA arrays [J]. Science. 1996,274:610-614
22． Chen MS, Huber AB, et al. Nogo-A is a myelin-associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1[J]. Nature. 2000,403:434-439
23． Chida D, Wakao H, et al.Transcriptional regulation of the beta-casein gene by cytokines: cross-talk between STAT5 and other signaling molecules [J]. Mol Endocrinol. 1998, 12 (11) : 1792-1806
24． Chomczynsli P, Sacchi N. Single step method of RNA by Acid Guanidinium Thiocyanate phenol Chloroform from extraction. Analytical Biochemistry. 1987, 162:156-159
25． Convit A, De leon MT, et al. Specific hippocampal volume reductions in individuals at risk for Alzheimer's disease[J]. Neurobiol Aging. 1997,18:131-138
26． Coria F, Rubio I,et al. Alzheimer's disease, beta-amyloidosis, and aging[J]. Rev Neurosci. 1994, 5(4) : 275-292
27． Dawson GR, Seabrook GR,et al. Age-related cognitive deficits, impaired long-term potentiation and reduction in synaptic marker density in mice lacking the beta-amyloid precursor protein. Neuroscience [J]. 1999, 90(1) : 1-13
28． Dekkers D W, et al. Regulatory mechanisms of transmembrane phospholipid distributions and patho-physiological implications of transbilayer lipid scrambling[J]. Lupus. 1998, 7 (suppl 2) :s126-131
29． Delacourte A. Diagnosis of Alzheimer's disease[J]. Ann Biol Clin (Paris). 1998, 56 (2) : 133-142
30． de Waard V, van Achterberg TA,et al. Cardiac ankyrin repeat protein (CARP) expression in human and murine atherosclerotic lesions: activin induces CARP in smooth muscle cells[J]. Arterioscler Thromb Vase Biol. 2003, 23 (1) : 64-68
31． Dif F, Saunier E, et al. Cytokine-inducible SH2-containing protein suppresses PRL signaling by binding the PRL receptor[J]. Endocrinology. 2001, 142(12) : 5286-5293
32． Dower NA, Stone JC.RasGRP is essential for mouse thymocyte differentiation and TCR signaling[J]. Nat Immunol. 2000, 1(4) :317-321
33． Ebinu JO, Stone JC. RasGRP links T-cell receptor signaling to Ras[J]. Blood. 2000, 95(10) : 3199-3203．
34． E Sontag, V unbhakdi-Craig, et al. A novel pool of protein phosphatase 2A is asso-ciateed with microtubules and is regulated during the cell cycle[J]. J Cell Biology. 1995, 128, 1131-1144
35． EunSang Choe, John Q Wang. CREB and Elk-1 phosphorylation by metabotropic glutamate receptors in striatal neurons[J]. Int J mol med. 2002, 9:3-10
36． Ferguson GD, Herschman HR. Synaptotagmin IV: biochemistry, genetics, behavior, and possible links to human psychiatric disease[J]. Mol Neurobiol. 2001． 23(2-3) :173-185．
37． Ferrer I. Neurons and their dendrites in frontotemporal dementia [J]. Dement Geriata Disord. 1999,10: 55-58
38． Ferrer I, Marti E,et al. Dystrophic neurites of senile plaques are defective in proteins involved in exocytosis and neurotransmission[J]. J Neuropathol Exp Neurol. 1998,57(3) : 18-25
39． Fukutani Y, Cairns NJ, et al. Purkinje cell loss and astrocytosis in the cerebellum in familial and sporadic Alzheimer's disease[J]. Neurosci Lett. 1996, 14(1) : 33-36
40． Garcia-Frigola C, Soriano E. Mouse Tspan-5, a member of the tetraspanin superfamily, is highly expressed in brain cortical structures[J]. Neuroreport. 2000, 11(14) : 3181-3185
41． Garcia-Frigola C, Soriano E. Pattern of expression of the tetraspanin Tspan-5 during brain development in the mouse[J]. Mech Dev.2001, 106(1-2) : 207-212
42． Ginsberg SD, Hemby SE, Lee VM. Expression profile of transcripts in Alzheimer's disease tangle-bearing CA1 neurons. Ann Neurol, 2000,48(1) : 77-87
43． Gong CX, Singh TJ, et al. Phosphoprotein phosphatase activities in Alzheimer disease brain[J]. J Neurochemistry. 1993, 61, 921-927
44． Gong CX, sheikh S, Wang J Z et al. Phosphatases activity towarde abnormally phosphorylated tau: decrease in Alzheimer disease brain[J]. J Neurochem. 1995, 65:732-741
45． Grane X, Reddy EP. Cell cycle control in mammalian cells: role of cyclins, cyclin dependent kinases (CDKs), growth suppressor genes and cyclin dependent kinase inhibitors (CKIs)[J]. Oncogene. 1995,11(2) :211-219
46． Grinidmsn Y, De Toledo-Morrell T, et al. Aged rats need a preserved complement of perforated axospinous synapses per hippocampal neuron to maintain good spatial memory [J]. Brain Res. 1986, 398: 266-275
47． Guo ZH, Mattson MP. In vivo 2-deoxyglucose administration preserves glucose and glutamate transport and mitochondrial function in cortical synaptic terminals after exposure to amyloid beta-peptide and iron: evidence for a stress response[J]. Exp Neurol. 2000, 166(1) : 173-179
48． Hamada N, Toyoda T. Molecular cloning and characterization of the mouse reticulon 3 cDNA [J]. Cell Mol Biol (Noisylegrand). 2002． 48(2) : 163-72
49． Harmon GJ, beach D. 15 INK4B is a potentiall effector of TGF-beta-induced cell cycle arrest [J]. Nature. 1994, 371: 257-261
50． Haughey NJ, Liu D, Mattson MP.et al.Disruption of neurogenesis in the subventricular zone of adult mice, and in human cortical neuronal precursor cells in culture, by amyloid beta-peptide: implications for the pathogenesis of Alzheimer's disease[J]. Neuromolecular Med 2002,1(2) : 125-135
51． Hemler ME. Specific tetraspanin functions[J]. J Cell Biol. 2001, 155(7) : 1103-1107
52． HerrCJ. Cancer cell cycles [J]. Science. 1996, 274(12) : 1672-1677
53． Higashitsuji H, Itoh K,et bl.Reduced stability of retinoblastoma protein by gankyrin, an oncogenic ankyrin-repeat protein overexpressed in hepatomas[J]. Nat Med 2000, 6(1) : 96-99
54． Ho L, Guo Y, Spielman L,et al. Altered expression of a-type but not b-type synapsin isoform in the brain of patients at high risk for Alzheimer's disease assessed by DNA microarray technique[J]. Neurosci Lett. 2001, 298(3) : 191-194
55． Hsu KS, Huang CC,et al. Alterations in the balance of protein kinase and phosphatase activities and age-related impairments of synaptic transmission and long-term potentiation[J]. Hippocampus. 2002, 12 (6) : 787-802
56． Huschtscha LI, Reddel RR. P16INK4a and the control of cellular prolife-rative life span [J]. Carcinogenesis, 1999, 20: 921-926
57． Iqbal K, Grundke-Iqbal I. Mechanism of Alzheimer neurofibrillary degeneration and the formation of tangles[J]. Mol Psychiatry. 1997, 2: 178-180
58． Itoh Y, Yamada M,et al.An immunohistochemical study of centenarian brains: a comparison[J]. J Neural Sci. 1998, 57(1) :73-81
59． Ji-Sheng Han. Acupincture: neuropeptide release produced by electrical stimulation of different frequencies[J]. Trends in neurosciences. 2003,26(1) : 17-22
60． Julia Mills, Peter B. Reiner. Regulation of Amyloid Precursor Protein Cleavage[J]. Journal ofNeurochemistry.1999, 72(2) :443-460
61． Kato H, Itoyama Y. Postischemic changes in the immunophilin FKBP12 in the rat brain [J]. Mol Brain Res. 2000, 84(l-2) :58-66
62． Khatoon S, Iqbal K. Brain levels of microtubule-associated protein tau are elevated in Alzheimer's disease: a radio immunoslotblot assay for nanograms of the protein[J]. J
Neurochem. 1992,59(2) : 750-753
63． Khatoon S, Iqbal K. Guanosine triphosphate binding to p-subunit of tubulin in Alzheimer's disease brain: role of microtubule-associated protein tau[J]. J Neurochem. 1995,64(2) : 777-787
64． King RW. How proteolysis drives the cell cycle[J]. Science. 1996, 274 (5293) : 1652-1659
65． Kluck RM, Bossy-Wetzel E. Green DR, et al. The release of cytochrome C from mitochondria: A primary Site for Bcl-2 regulation of apoptosis[J]. Science. 1997, 275(21) : 1132-1136
66． Krupp J J, et al. Interactions of calmodulin and a-actinin with the NR1 subunit modulate Ca2+-dependent inactivation of NMDA receptors[J]. J Neurosci. 1999,19: 1165-1172
67． Kuchler S, Zanetta JP. Mannose dependent tightening of the rat ependymal cell barrier. In vivo and in vitro study using neoglycoproteins[J]. Neurochem Int. 1994, 24(1) : 43-55
68． Lanzrein AS, Sim E. Mannan-binding lectin in human serum, cerebrospinal fluid and brain tissue and its role in Alzheimer's disease[J]. Neuroreport. 1998, 9(7) : 1491-1495
69． Le Blanc A, et al. Caspase-6 Role in Apoptosis of Human Neurons, Amyloid-ogenesis. and Alzheimer's Disease[J]. J Biol Chem. 1999,274:23426-23436
70． Leuba G, Kraftsik R . Visual cortex in Alzheimer's disease: occurrence of neuronal death and glial proliferation, and correlation with pathological hallmarks. Neurobiol Aging. 1994, 15(1) : 29-43
71． Lin, A. W., M. Barradas, et al. Premature senescence involving p53 and p16 is activated in response to constitutive MEK/MAPK mitogenic signaling[J]. Genes. 1998, 12: 3008-3019
72． Lippa CF, Nee LE, et al. Aβ42 deposition precedes other changes in PS-1 Alzheimer' s disease[J]. Lancet. 1998, 352: 1117-1118
73． Liu J, Tong Y K, Liu H, et at. Effect of P15INK4b expression on the cell cycle and Gl phase related regulatory gene in human melanoma cells [J]. Progress in Natural Science. 2001; 11(1) : 40-45
74． Loring JF; Wen X; Fuhrman S; Seilhamer J. Use of gene expression microarrays to MAP molecular pathology in Alzheimer disease brain. Society for Neuroscience . 2000． 26(1-2) :833-835
75． Loring JF, Wen X, Lee JM, Seilhamer J, Somogyi R. A gene expression profile of Alzheimer's disease. DNA Cell Biol. 2001,20(11) :683-695
76． Lukiw WJ, McLachlan DR. Cytoskeletal messenger RNA stability in human neocortex: studies in normal aging and in Alzheimer's disease[J]. Int J Neurosci. 1990, 55(2-4) :81-88
77． Mackler JM, Reist NE. The C(2) B Ca(2+)-binding motif of synaptotagmin is required for synaptic transmission in vivo[J]. Nature. 2002, 418(6895) : 340-344
78． Magavi SS, Leavitt BE, et al. Nature.2000,405:892( 刘璇等 ,2003 引用 )
79． Marcos Malumbres, Ignacio Perez, et al. Cellular Response to Oncogenic Ras Involves Induction of the Cdk4 and Cdk6 Inhibitor p15INK4b [J]. Molecularand Cellular Biology. 2000, 20(8) : 2915-2925
80． Markus EJ. Petit TL. Synaptic structural plasticity: Role of synaptic shape[J]. Synapse. 1989,3: 1-11
81． Matsumoto A, Seki Y, et al.Suppression of STAT5 functions in liver, mammary glands, and T cells in cytokine-inducible SH2-containing protein 1 transgenic mice. Mol Cell Biol[J]. 1999, 19(9) :6396-6407
82． McGeer P. L, Rogers J. et al. Neuroimmune mechanisms in Alzheimer disease pathogenesis. [J] Alzheimer Disease and Associated Disorders[J]. 1994,8:149-165
83． McKee AC; Follettie M T. Gene expression profiling in Alzheimer's disease brain by DNA microarrays .Society for Neuroscience. 2000,26(1-2) : 839-846
84． McShea A, Harris PL, Webster KR et al. Abnormal expression of the cell cycle regula-tors p16 and CDK4 in Alzheimer's disease[J]. Am J Pathol, 1997, 150(6) : 1933-1939
85． Meier-Ruge W, Iwangoff P, et al. What is primary and what secondary for amyloid disposition in Alzheimer's disease [J]. Ann NY Acad Sci. 1994, 719:230-235
86． Meltzer CC, Smith G, DeKosky ST, et al. Serotomin in Aging, Late-Life Depression, and Alzheimer's Disease: The Emerging Role of Functional Imging [J]. Neuropsy-cho pharmacology. 1998, 18:407-430
87． Morrison J, Hof P. Life and death of neurons in the aging brain [J]. Science. 1997,278: 412-419
88． Mori K, Ogawa Yet al.Kidney-specific expression of a novel mouse organic cation transporter-like protein [J]. FEBS Lett. 1997, 417(3) :371-374
89． Mufson EJ; Ginsberg S D. Expression profile of cholinergic basal forebrain neurons in
mild Alzheimer's disease using gene microarrays. Society for Neuroscience. 2000, 26(1-2) :835-842
90． Mufson EJ; Ginsberg S D . Single cell and regional cDNA microarray analysis of cholinergic basal forebrain neurons in aged and Alzheimer's disease brain. Society for Neuroscience. 2001,27(1) :253-261
91． Mukaetova-Ladinska EB, Harrington CR,et al.Alterations in tau protein metabolism during normal aging [J]. Dementia 1996, 7(2) :95-103
92． Nagy ZS, Esiri MM. Apoptosis-related protein expression in the hippocampus in Alzheimer's disease. Neurobiol Aging. 1998,18:565-571
93． Nayak AS, Moore CI, et al.Ca2+/calmodulin-dependent protein kinase Ⅱ phosphorylation of the presynaptic protein synapsin I is persistently increased during long-term potentiation [J]. Proc Natl Acad Sci USA. 1996, 93(26) : 15451-15456
94． Nelson JS. Alzheimer athology in elderly patients with glioblastoma multiforme [J]. Arch Pathol Lab Med. 2002, 126(12) :1515-1517
95． Nishimura M, Namba Y, et al. Glial fibrillary tangles with straight tubules in the brains of paitients with progressive supranuclear palsy [J]. Neurosci Lett. 1992,143:35-38
96． Ono T, Yamamoto H,et al. Dephosphorylation of abnormal sites of tau factor by protein phosphatases and its implication for Alzheimer's disease [J]. Neurochem Int 1995 , 26(3) : 205-215
97． Palacios G, Mengod G, et al. Increased beta-amyloid precursor protein expression in astrocytes in the gerbil hippocampus following ischaemia: association with proliferation of astrocytes[J]. Eur J Neurosci. 1995, 7(3) : 501-510
98． Pasinetti GM, Ho L. From cDNA microarrays to high-throughput proteomics. Implications in the search for preventive initiatives to slow the clinical progression of Alzheimer's disease dementia.Restor Neurol Neurosci,2001,18(2-3) :137-142 a
99． Pasinetti GM. Use of cDNA microarray in the search for molecular markers involved in the onset of Alzheimer's disease dementia. J Neurosci Res. 2001,65(6) : 471-476 b
100． Petersen RC, Smith GE, et al. Mild cognitive impairment: clinical characterization and outcome[J]. Arch Neurol, 1999, 56: 303-308
101． Pezet A, Favre H, et al.Inhibition and restoration of prolactin signal transduction by suppressors of cytokine signaling[J]. J Biol Chem . 1999 , 274(35) : 24497-24502
102． Pluta R, Misicka A, Nidan RU, et al. Transport of human beta-amyloid peptide through the rat blood brain barrier after global cerebral ischemia[J]. Acta Neurochir, 1997, 70 (suppl): 247-249
103． Prinjha R, Moore SE, et al. Inhibitor of neurite outgrowth in humans[J]. Nature. 2000, 403: 383-384
104． Reddy PH; Teng S; Yu P. Differential expression of genes in Alzheimer's disease using cDNA microarrays. Society for Neuroscience. 2000,26 (1-2) : 834-840
105． Rogers J. Cooper N R. et al. Compliment activation by p-amyloid in Alzheimer's disease[J]. Proceedings of the National Academy of Science. U.S.A. 1992,89:1016-1020
106． Rosehl T W, Gappert M, et al. Short-term synaptic plasticity is lacking in mice lacking synapsin I [J]. Cell. 1993, 75(4) : €61-676
107． Rumny NJ. The aging eye and vision appliances [J]. Ophthalmid and Physiology Optics. 1998, 18: 191-196
108． Sadowski CL, Wheeler TT, et al. GH regulation of IGF-I and suppressor of cytokine signaling gene expression in C2C12 skeletal muscle cells[J]. Endocrinology. 2001 S. 142 (9) : 3890-3900
109． Saegusa M, Machida B D, et al.Possible associations among expression of p!4(ARF). p16(INK4a), p21(WAFl/CIPl),p27(KIPl), and p53 accumulation and the balance of apoptosis and cell proliferation in ovarian carcinomas[J]. Cancer. 2001, 92(5) : 1177-1189
110． Satou T, Cummings BJ, Head E, Cotman CW.et al. The progression of beta-amyloid deposition in the frontal cortex of the aged canine[J]. Brain Res. 1997,774(l-2) :35-43
111 .Scheuner D, Eckman C, et al. Secreted amyloid beta-protein similar to that the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease[J]. Nat Med. 1996,15: 2864-2870
112． Sengupta A, Kabat J, et al. Phosphorylation of tar at both Thr 231 and Ser 262 is required for maximal inhibition of its binding to microtubules[J]. Arch Biochem Biophys. 1998, 357: 299-309
113． Sennvik, Benedikz E, Fastbom E, et al. Calcium ionophore A23187 specifically decreases the secretion of beta-secretase cleaves amyloid precursor protein during apoptosie in primary rat cortical cultures[J]. J Neurosci Res. 2001, 63: 429-437
114． Sergeant N, David JP,et al.Two-dimensional characterization of paired helical filament-tau from Alzheimer's disease: demonstration of an additional 74-kDa component and age-related biochemical modifications [J]. J Neurochem. 1997 , 69(2) : 834-844
115． Shoemaker D D, Lash kari D A, et al. Quantitative phenotypic analysis of years deletion mutants using a highly parallel molecular bar coding strategy[J]. J Nat genet. 1996, 14: 450-456
116． Sironi J J, Yen S H, et al. Ser-262 in human recombinant tau protein is a markedly more favorable site for phosphorylation CaMK II than PKA or PhK [J]. FEBS Lett. 1998, 336: 417-475
117． Sontag E, Nunbhakdi-Craig V, et al. Molecular interactions among protein phosphatase 2A, tau, and microtubules. Implications for the regulation of tau phosphorylation and the development of tauopathies [J]. J Biol Chem. 1999, 274(36) : 25490-25498
118． Spence J, Finley D. Cell cycle-regulated modification of the ribosome by a variant multiubiquitin chain[J]. Cell. 2000, 102( 1) : 67-76．
119． Sze CI, Bi H, leinschmidt-DeMasters BK, et al. Selective regional loss of exocytotic presynaptic vesicle proteins in Alzheimer's disease brains [J]. J Neurol Sci. 2000, 175 (2) : 81-90
120． Tagami S, Eguchi Y,et al.A novel protein, RTN-XS, interacts with both Bel-XL and Bcl-2 on endoplasmic reticulum and reduces their anti-apoptotic activity [J]. Oncogene. 2000, 19(50) : 5736-5746
121． Takahashi J, Paimer T D, et al. Retinoic acid and neurocrophins collaborate to regulate neurogenesis in adule-derived neural stem cell cultures [J]. J Neurobiology. 1999, 38 (1) : 65-81
122． Takeda T, Hosokawa M, Higuchi K. Senescence-Accelerated Mouse(SAM): A novel murine model of accelerated senescence [J]. Geriatric Bioscience. 1991, 39(9) : 911-919
123． Takeda T, Hosokawa M, Higuchi K, Hosono M, Akiguchi I, Katoh H. A novel murine model of aging; Senescence-Accelerated-Mouse[J]. Arch Gerontol Geriatr. 1994,19: 185-192
124． Takeda T, Matsushita T, Kurozumi M, Takemura K, Higuchi K, Hosokawa M. Pathobiology of the Senescence Accelerated Mouse (SAM) [J]. Exp Gerontol. 1997, 32: 117-127
125． Tong Y K, Liu H. p15--a new turner suppressor gene [J]. Chinese Science Bulletin. 1999, 44(13) :1157-1163
126． Tucker WC, Chapman ER. Role of synaptotagmin in Ca2+-triggered exocytosis[J]. Biochem J. 2002, 15 (366) : 1-13．
127． Van Gool D, Carmeliet G,et al.Appearance of localized immunoreactivity for the alpha 4 integrin subunit and for fibronectin in brains from Alzheimer's, Lewy body dementia patients and aged controlsfJ]. Neurosci Lett. 1994, 170(1) :71-73
128． Vossoughi J, Vaishnav RN.Comments on the paper "Volume Compressibility of Human Abdominal Skin"[J]. J Biomech. 1979, 12(6) : 481-489
129． Vogt BA, Vogt LJ, Van Hoesen GW. et al. Multivariate analysis of laminar patterns of neurodegeneration in posterior cingulate cortex in Alzheimer's disease[J]. Exp Neurol 1998,153(l):8-22
130． Vrensen G, Nunes Cardozo. Changes in size and shape of synaptic connection after visual training: An ultrastructural approach of synaptic plasticity [J]. Brain Res. 1981, 218:79-97
131． Yoshimura A, Ohkubo T,et al.A novel cytokine-inducible gene CIS encodes an SH2-containing protein that binds to tyrosine-phosphorylated interleukin 3 and erythropoietin receptors[J]. EMBO J. 1995, 14(12) : 2816-2826
132． Wang J Z, Grundke-Iqbal I, Iqbal K. dephosphorylation of Alzheimer soluble abnormally phosphorylated tau by PP-2A, PP-2B and PP-1[J]. Mol Brain Res.1996, 38: 200-207,
133． Ying W. Deleterious network hypothesis of Alzheimer's disease[J]. Med Hypothesis. 1996,46:421-428
134． Yu Shang Cai, Li Xiao Yu. Alzheimer's of apoptosis[J]. Chin J Neutoinmmunol & Neuro. 1999,6(l):5459-5466
135． Zambrzycka A, Alberghina M, Strosznajder JB. Effects of aging and amyloid-beta peptides on choline acetyltransferase activity in rat brain[J]. Neurochem Res.2002,27(4) :277-281
136． Zhu J, D. Woods, et al. Senescence of human fibroblasts induced by oncogenic Raf. Genes.1998, 12: 2997-3007
137． Z. Nagy, M.M. Esiri. et al. Cell cycle markers in the hippocampus in Alzheimer's disease. Acra Neuropathologica.1997, 94(1) : 6-15
138．Peter Duus 著，刘宗惠，胡威夷等译．神经系统疾病定位诊断学—解剖、生理、临床．北京，海洋出版社，1995．a：224
139．I．B 莱维坦等著，舒斯云等译．神经元：细胞和分子生物学．第一版，北京，科学出版社，2001．a：18：b：140-141；c：88；d：27；e：264；f：155
140．R．J．B．金著，刘以训等译．癌生物学．北京：科学出版社，2002．a：110；b：136
141．蔡大勇，赵雁．D-半乳糖致原代培养神经元损伤模型的研究[J]．中国病理生理杂志．2002，18(7)：794-797
142．车林海，贾建平．老年期痴呆 129 例的临床研究[J]．中风与神经疾病杂志．2002．19(4)：213-215
143．陈俊抛等主编．痴呆治疗学，人民军医出版社，北京，2002．a：19；b：41
144．陈水灿．古代针灸益智临床经验节要[J]．中国针灸．1997，17(5)：312
145．成丽俊．基因芯片技术及其在医学中的应用[J]．国外医学计划生育分册．2001．20(2)：66-71
146．陈可冀主编．新编抗衰老中药学．北京：人民卫生出版社．1998：153
147．陈可冀主编．跨世纪脑科学·老年痴呆发病理与诊治．北京医科大学、中国协和医科大学联合出版社．1998：309
148．崔天益，周新等．载脂蛋白 E 基因多态性与散发性老年性痴呆病的关系[J]．中国病理生理杂志．2000，16(8)：741-743 a
149．崔天益，周新等．早衰蛋白-1 基因内含子多态性与 Alzheimer's 病的关系[J]．基础医学与临床．2000，20(4)：21-23 b
150．崔云华．细胞外基质与细胞周期调控[J]．国外医学分子生物学分册．2002，24(1)：47-49
151．董洪涛．金渊光等．针刺治疗老年性痴呆 11 例[J]．上海中医药大学学报．2002，16(3)：26-28
152．董洪涛，房縏恭．多因素 AD 动物模型的建立及针刺对其学习记忆功能的影晌[J]．上海中医药杂志．2002，5：43-46
153．杜红燕，张维宁等．两组不同月龄小鼠学习记忆能力与脑突触体内游离[Ca~(2+)]i 的相关性[J]．生理学报．1996，48：43-47
154．冯方俊，涂晋文．寿尔智胶囊对老年性痴呆模型鼠海马神经元 c-fos、[Ca~(2+)]i 的影响[J]．湖北中医学院学报．2002，4(3)：16-18 a．
155．冯方俊，涂晋文．寿尔智胶囊对衰老模型鼠行为学影响的实验研究[J]．湖北中医杂］志．2002，24(7)：3-4 b．
156．付东红．我校童坦君、张宗玉教授发现 P16 基因的作用机理．www.pku.edu.cn/news/xiao_kan/news/203/03-05.htm
157．高静，等．行为训练与小鼠海马突触蛋白的磷酸化水平的相关性[J]．生理学报．1992，44(1)：86-91
158．高希言，关晨霞．针灸督脉经穴对小鼠学习记忆和胆碱酯酶活性的影响[J]．国医论坛．2001，16(2)：55-56
159．顾智磊：吴政红等．ApoE 基因型多态性与老年性痴呆的相关性．上海第二医科大学学报．2001．21(4)：325-327
160．韩杰，王琳等．阿尔兹海默病不同阶段的临床神经心理学研究[J]．中国神经精神疾病杂志．2002，28(1)：45-46
161．韩济生主编．神经科学原理．第二版，北京，北京医科大学出版社，2001．a：988；b：536；c：997；d：394；e：363；f：888-890；g：307；h：409
162．景献．日本快速老化模型小白鼠(SAM)老化诸特征[J]．实验动物与管理．1995，12(4)：21-29
163．胡爱群，王桐．阿尔兹海默病老年斑研究进展[J]．国外医学·老年医学分册．2001．22(2)：74-77
164．胡海峰，朱宝泉．乙酰胆碱酯酶及其抑制剂的研究进展．国外医药抗生素分册．1999，20(2)：81-87
165．冀成君，金弘敏．痴呆病人 ApoE 基因检测与多态性分析[J]．现代康复．2000，4(10)：1524-1525
166．贾建平、贾健民等．阿尔兹海默病和血管性痴呆患者脑脊液中乙酰胆碱和胆碱检测及其临床意义[J]．中华神经科杂志．2002，35(3)：168-170
167．姜国华，魏群科技时报钙调神经磷酸酶 B 亚基的~(125)Ⅰ标记及其血脑屏障的通透性[J]．同位素．2001，8(3-4)：201-205
168．科学时报．老而不衰基因定夺．www.cas.ac.cn/html/Dir/2003/02/12/7022.htm
169．李亚．秦海强等．β-淀粉样蛋白对D-半乳糖致衰大鼠行为及海马 SOD 活性和 MDA 含量的影响[J]．中国病理生理杂志．2001，17(1)：16-18
170．刘昌．李德明．大脑老化研究及其进展[J]．自然杂志．1996，18(5)：286-290
171．刘长春．文孟良．生物芯片[J]．分析仪器．2001，3：37-39
172．刘强．杨琳．大鼠心脏与内关穴区神经投射同源关系的非荧光双标记示踪[J]．解部学杂志．2002．25(1)：39-41
173．刘庆忠，郑灏泳．针刺对快速老化痴呆模型小白鼠红细胞变形能力影响的实验研究[J]．中国针灸．2001，21(5)：309-310
174．刘薇，卢光秀．阿尔茨海默病相关 PDAPSW 转基因小鼠模型的表型研究[J]．中华神经科杂志．2002，35(4)：201-203
175．刘勇林，李晨旭等．脑内一氧化氮对大鼠学习功能的影响[J]．北京医科大学学报．1996，28：306
176．刘一凡，石学敏．针刺对快速老化脑萎缩模型小鼠脑抗氧化酶活性的影响[J]．中国针灸．2002，22(5)：327-330
177．刘璇，林万敏等．成年神经干细胞研究现状．细胞生物学杂志．2003，25(1)：1-5
178．裴印权，苏丹．NMAD 受体和其拮抗剂的药理[J]．中国药理学通报．1996，12：303-306
179．钱卓．脑功能基因组学的研究．CETV口：学术报告厅．2003-1-29(10：45PM)
180．司徒镇强，吴军正主编．细胞培养[M]．第1版．西安世界图书出版公司出版．1999，121-124，181-210
181．瞿正万，顾立铭．老年期痴呆忠者脑室脑沟扩大与认知障碍的相关性分析[J]．心理科学．1999，22：373-374，370
182．盛建华，高之旭等．轻至中度阿尔茨海默病患者认知和生活功能的自然演变[J]．中国神经精神疾病杂志．2002，28(1)：30-32
183．盛树力．老年性痴呆：从分子生物学到临床诊治．北京：科学技术文献出版社．1999，351-355
184．石学敏，韩景献等．针刺对老化痴呆鼠脑兴奋性氨基酸水平影响的实验研究[J]．中国针灸．1998，11：689-692，793
185．王德生，张守信主编．老年性痴呆．第一版，北京，人民卫生出版社，2001．a：373；b：97-161；c：153-156；d：229；e：181c f：65-69；h：218
186．王哲，周昌玉 Hp 感染与老年胃癌及癌前病变中 bcl-2、p16、c-myc 基因表达的关系[J]．中国老年学杂志．2002，7(22)：264-266
187．王升启．基因芯片技术及应用研究进展[J]．生物工程进展．1999，19(4)：45-50
188．汪义朋，王群．阿尔茨海默病患者神经细丝 mRNA 含量及突变的检测[J]．中华医学杂志．2002，82(8)：519-522
189．王振龙．醒脑开窍加体针治疗老年性痴呆[J]．针灸临床杂志．1997，13(9)：16
190．魏小龙，张永祥．老年性痴呆动物模型研究进展．中国药理学通报．2000，16(4)：372-376
191．温廷益，韩景献．针刺对快速老化鼠脑、肝细胞核活性基因的影响[J]．中医杂［
志，2002，43(1)：28-29
192．吴馥梅，杜红燕等．突触界面曲率及其生理意义[J]．神经解剖学杂志，1994，10：89-92
193．吴馥梅，肖信生．神经肽与学习记忆．姚志彬等主编．脑研究前沿，广东科技出版社，1995：268-290
194．吴哲，孙黎光等．穹窿海马伞切断大鼠海马 PKC 和 ERK 活性的变化[J]．中风与神经疾病杂志．2002，19(4)：216-219
195．夏保芦，程标．电针“内关”穴抗过敏性休克作用与脑内催产素含量的关系[J]．针刺研究．2001，26(1)：10-14
196．项志清，陈月敏等．阿尔兹海默病的扩瞳试验研究[J]．中华精神科杂志．2001，34(1)：1-3
197．谢建军，胡亚美．泛素-蛋白酶体途径恶性肿瘤、关系的研究进展[J]．中国癌症杂志．2002，12：74-76
198．徐敏．载脂蛋白 E 与老年痴呆研究新进展[J]．现代康复．2001，5(8A)：60-61
199．徐天乐．神经元钙信号的分子机制[J]．申经解剖学杂志．1998，14：195
200．许绍芬主编．神经生物学．第二版，上海，上海医科大学出版社，1999．a：58；b：10-15；c：477-480；d：74
201．严振国主编．中医应用腧穴解剖学．上海中医药大学出版社，2001，P50，23，102，105
202．杨增瑞，来丽萍等．针刺对快速老化痴呆模型小白鼠脑内ACH含量及ACHE活性影响的实验研究[J]．天津中医．1999，16(3)：20-21
203．曾湘豫，秦斌．脑脊液 Aβ42 和 tau 蛋白的联合测定——有望成为 Alzheimer 病早期诊断的生物学参数[J]．中国神经免疫学和神经病学杂志．2002，9(1)：39-41
204．章静波，林建银等．医学分子细胞生物学．中国协和医科大学出版社，2002．a：91；b：323
205．张转．GSTs 与肿瘤及其化疗耐药之间的关系[J]．肿瘤防治研究．2000，27(6)：498．501
206．张春红，王舒．针刺对局灶性脑缺血大鼠脑细胞凋亡的影响[J]．针刺研究．2001，26(2)：102-105
207．张林杰．微阵列技术及其应用[J]．国外医学分子生物学分册．2001，23(1)：46-48
208．周乐全，张晓东等．补肾益智方对痴呆模型大鼠学习记忆能力的影响[J]．中医研究．2001，14(2)：23-25
209．朱粹青，曹小定．蛋白磷酸酶(PP)-1和-2A抑制剂对 NG108-15 细胞 tau 蛋白磷酸化的影响[J]．细胞生物学杂志．2002，24(2)：115-117
210．朱长庚主编．神经解剖学．第一版，北京，人民卫生出版社．2002．a：235-246；b：529-533；c：502；d：506；e：472；f：479
2． Alonso AC, Grundke H, Iqbal K. Alzheimer's disease hyperphosphorylated tau sequesters normal tau into tangles of filaments and disassembles microtubules[J]. Nature Med, 1996． 2:783-785
3． Arendt T, Holzer M, et al. Paired helical filament-like phosphorylation of tau, deposition of beta/A4-amyloid and memory impairment in rat induced by chronic inhibition of phosphatase 1 and 2A[J]. Neuroscience 1995; 69(3) :691-698
4． Arendt T, Rodel L, Gartner U, Holzer M. Expression of the cyclin-dependent kinase inhibitor p16 in Alzheimer's disease[J]. Neuroreport .1996, 7(18) : 3047-3049 Arendt T, Holzer M, Gartner U. Neuronal expression of cycline dependent kinase inhibitors of the INK4 family in Alzheimer's disease[J]. J Neural Transm 1998; 105 (8-9) : 949-960
6． Arendt T. Dysregulation of neuronal differentiation and cell cycle control in Alzheimer's disease[J]. J Neural Transm Suppl. 2002, (62) : 77-85
7． Argiles JM, Busquets S.et al.The role of uncoupling proteins in pathophysiological states [J]. Biochem Biophys Res Commun. 2002, 293 (4) : 1145-1152
8． Andrea LeBlanc, Hui Liu. Caspase-6 Role in Apoptosis of Human Neurons, Amyloidogenesis, and Alzheimer's Disease[J]. J Biol Chem, 1999, 274: 23426-23436
9． Barria A, Muller D, et al. Regulatory phosphorylation of AMPA-type glutamate receptors by CaMK-Ⅱ during long-term potentiation[J]. Science, 1997, 276:2042-2045
10． Liu Q, Berg DK. Actin filament and the opposing actions of CaM kinase and calcineurin in regulating α7-containing nicotine receptors on chick ciliary ganglion neurons[J]. J Neurosci. 1999, 19:10280-10289
11． Bertoni-Freddaei C, Giuli C. et al. Quantitative investigation of the morphological plasticity of synaptic junction in rat dentate gyrus during aging[J]. Brain Res. 1986． 366:
187-192
12． Bertoni-Freddari C, Fattoretti P, et al. Morphological adaptive response of the synaptic junction zones in the human dentate gyrus during aging and Alzheimer's disease[J]. Brain Res. 1990, 517:69-75
13． Bikelenbom P. Zhan S S. et al. Inflammatory mechanisms in Alzheimer's disease [J]. Trends in Pharmacological Sciences. 1994, 15: 447-450
14． Bouras C, Hof PR,et al. Regional distributeon of neurofibrillary tangles and senile plaques in the cerebral cortex of elderly patients: a quantitative ebaluation of a one-year autopsy population from a geriatric hoxpital. Cereb Cortex. 1994,4, 138-150
15． Bouvier-Labit C, Civatte M, Figarella-Branger D.et al.p16INK4a and p19INK4d mRNA expression in neuroglial tumours: correlation with Ki67 proliferation index[J]. Neuropathol Appl Neurobiol. 1999,25(5) :408-416
16． Braak H. Braak E.Evaluation of the neuroupathology of Alzheimer's diseaee[J]. Acta Neurologica Scand. 1996, 93(Suppl): 3-9
17． Buee L, Hof PR, et al. Brain microvascular changes in Alzheimer's disease and other dementias[J]. Ann NY Acad Sci. 1997; 826: 7-24
18． Burton T, Liang B,et al.Transcriptional activation and increase in expression of Alzheimer's beta-amyloid precursor protein gene is mediated by TGF-beta in normal human astrocytes[J]. Biochem Biophys Res Commun. 2002, 295 (3) : 702-712
19． Busser J, Geldmacher DS, Herrup K. Ectopic cell cycle proteins predict the sites of neuronal cell death in Alzheimer's disease brain[J]. J Neurosci . 1998 ,15;18 (8) : 2801-2807
20． Charlws J. Sherr. Cancer cell cycles [J]. Science. 1996, 274(5293) : 1672-1677
21． Chee M, Yang R, et al. Accessing genetic information with high-density DNA arrays [J]. Science. 1996,274:610-614
22． Chen MS, Huber AB, et al. Nogo-A is a myelin-associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1[J]. Nature. 2000,403:434-439
23． Chida D, Wakao H, et al.Transcriptional regulation of the beta-casein gene by cytokines: cross-talk between STAT5 and other signaling molecules [J]. Mol Endocrinol. 1998, 12 (11) : 1792-1806
24． Chomczynsli P, Sacchi N. Single step method of RNA by Acid Guanidinium Thiocyanate phenol Chloroform from extraction. Analytical Biochemistry. 1987, 162:156-159
25． Convit A, De leon MT, et al. Specific hippocampal volume reductions in individuals at risk for Alzheimer's disease[J]. Neurobiol Aging. 1997,18:131-138
26． Coria F, Rubio I,et al. Alzheimer's disease, beta-amyloidosis, and aging[J]. Rev Neurosci. 1994, 5(4) : 275-292
27． Dawson GR, Seabrook GR,et al. Age-related cognitive deficits, impaired long-term potentiation and reduction in synaptic marker density in mice lacking the beta-amyloid precursor protein. Neuroscience [J]. 1999, 90(1) : 1-13
28． Dekkers D W, et al. Regulatory mechanisms of transmembrane phospholipid distributions and patho-physiological implications of transbilayer lipid scrambling[J]. Lupus. 1998, 7 (suppl 2) :s126-131
29． Delacourte A. Diagnosis of Alzheimer's disease[J]. Ann Biol Clin (Paris). 1998, 56 (2) : 133-142
30． de Waard V, van Achterberg TA,et al. Cardiac ankyrin repeat protein (CARP) expression in human and murine atherosclerotic lesions: activin induces CARP in smooth muscle cells[J]. Arterioscler Thromb Vase Biol. 2003, 23 (1) : 64-68
31． Dif F, Saunier E, et al. Cytokine-inducible SH2-containing protein suppresses PRL signaling by binding the PRL receptor[J]. Endocrinology. 2001, 142(12) : 5286-5293
32． Dower NA, Stone JC.RasGRP is essential for mouse thymocyte differentiation and TCR signaling[J]. Nat Immunol. 2000, 1(4) :317-321
33． Ebinu JO, Stone JC. RasGRP links T-cell receptor signaling to Ras[J]. Blood. 2000, 95(10) : 3199-3203．
34． E Sontag, V unbhakdi-Craig, et al. A novel pool of protein phosphatase 2A is asso-ciateed with microtubules and is regulated during the cell cycle[J]. J Cell Biology. 1995, 128, 1131-1144
35． EunSang Choe, John Q Wang. CREB and Elk-1 phosphorylation by metabotropic glutamate receptors in striatal neurons[J]. Int J mol med. 2002, 9:3-10
36． Ferguson GD, Herschman HR. Synaptotagmin IV: biochemistry, genetics, behavior, and possible links to human psychiatric disease[J]. Mol Neurobiol. 2001． 23(2-3) :173-185．
37． Ferrer I. Neurons and their dendrites in frontotemporal dementia [J]. Dement Geriata Disord. 1999,10: 55-58
38． Ferrer I, Marti E,et al. Dystrophic neurites of senile plaques are defective in proteins involved in exocytosis and neurotransmission[J]. J Neuropathol Exp Neurol. 1998,57(3) : 18-25
39． Fukutani Y, Cairns NJ, et al. Purkinje cell loss and astrocytosis in the cerebellum in familial and sporadic Alzheimer's disease[J]. Neurosci Lett. 1996, 14(1) : 33-36
40． Garcia-Frigola C, Soriano E. Mouse Tspan-5, a member of the tetraspanin superfamily, is highly expressed in brain cortical structures[J]. Neuroreport. 2000, 11(14) : 3181-3185
41． Garcia-Frigola C, Soriano E. Pattern of expression of the tetraspanin Tspan-5 during brain development in the mouse[J]. Mech Dev.2001, 106(1-2) : 207-212
42． Ginsberg SD, Hemby SE, Lee VM. Expression profile of transcripts in Alzheimer's disease tangle-bearing CA1 neurons. Ann Neurol, 2000,48(1) : 77-87
43． Gong CX, Singh TJ, et al. Phosphoprotein phosphatase activities in Alzheimer disease brain[J]. J Neurochemistry. 1993, 61, 921-927
44． Gong CX, sheikh S, Wang J Z et al. Phosphatases activity towarde abnormally phosphorylated tau: decrease in Alzheimer disease brain[J]. J Neurochem. 1995, 65:732-741
45． Grane X, Reddy EP. Cell cycle control in mammalian cells: role of cyclins, cyclin dependent kinases (CDKs), growth suppressor genes and cyclin dependent kinase inhibitors (CKIs)[J]. Oncogene. 1995,11(2) :211-219
46． Grinidmsn Y, De Toledo-Morrell T, et al. Aged rats need a preserved complement of perforated axospinous synapses per hippocampal neuron to maintain good spatial memory [J]. Brain Res. 1986, 398: 266-275
47． Guo ZH, Mattson MP. In vivo 2-deoxyglucose administration preserves glucose and glutamate transport and mitochondrial function in cortical synaptic terminals after exposure to amyloid beta-peptide and iron: evidence for a stress response[J]. Exp Neurol. 2000, 166(1) : 173-179
48． Hamada N, Toyoda T. Molecular cloning and characterization of the mouse reticulon 3 cDNA [J]. Cell Mol Biol (Noisylegrand). 2002． 48(2) : 163-72
49． Harmon GJ, beach D. 15 INK4B is a potentiall effector of TGF-beta-induced cell cycle arrest [J]. Nature. 1994, 371: 257-261
50． Haughey NJ, Liu D, Mattson MP.et al.Disruption of neurogenesis in the subventricular zone of adult mice, and in human cortical neuronal precursor cells in culture, by amyloid beta-peptide: implications for the pathogenesis of Alzheimer's disease[J]. Neuromolecular Med 2002,1(2) : 125-135
51． Hemler ME. Specific tetraspanin functions[J]. J Cell Biol. 2001, 155(7) : 1103-1107
52． HerrCJ. Cancer cell cycles [J]. Science. 1996, 274(12) : 1672-1677
53． Higashitsuji H, Itoh K,et bl.Reduced stability of retinoblastoma protein by gankyrin, an oncogenic ankyrin-repeat protein overexpressed in hepatomas[J]. Nat Med 2000, 6(1) : 96-99
54． Ho L, Guo Y, Spielman L,et al. Altered expression of a-type but not b-type synapsin isoform in the brain of patients at high risk for Alzheimer's disease assessed by DNA microarray technique[J]. Neurosci Lett. 2001, 298(3) : 191-194
55． Hsu KS, Huang CC,et al. Alterations in the balance of protein kinase and phosphatase activities and age-related impairments of synaptic transmission and long-term potentiation[J]. Hippocampus. 2002, 12 (6) : 787-802
56． Huschtscha LI, Reddel RR. P16INK4a and the control of cellular prolife-rative life span [J]. Carcinogenesis, 1999, 20: 921-926
57． Iqbal K, Grundke-Iqbal I. Mechanism of Alzheimer neurofibrillary degeneration and the formation of tangles[J]. Mol Psychiatry. 1997, 2: 178-180
58． Itoh Y, Yamada M,et al.An immunohistochemical study of centenarian brains: a comparison[J]. J Neural Sci. 1998, 57(1) :73-81
59． Ji-Sheng Han. Acupincture: neuropeptide release produced by electrical stimulation of different frequencies[J]. Trends in neurosciences. 2003,26(1) : 17-22
60． Julia Mills, Peter B. Reiner. Regulation of Amyloid Precursor Protein Cleavage[J]. Journal ofNeurochemistry.1999, 72(2) :443-460
61． Kato H, Itoyama Y. Postischemic changes in the immunophilin FKBP12 in the rat brain [J]. Mol Brain Res. 2000, 84(l-2) :58-66
62． Khatoon S, Iqbal K. Brain levels of microtubule-associated protein tau are elevated in Alzheimer's disease: a radio immunoslotblot assay for nanograms of the protein[J]. J
Neurochem. 1992,59(2) : 750-753
63． Khatoon S, Iqbal K. Guanosine triphosphate binding to p-subunit of tubulin in Alzheimer's disease brain: role of microtubule-associated protein tau[J]. J Neurochem. 1995,64(2) : 777-787
64． King RW. How proteolysis drives the cell cycle[J]. Science. 1996, 274 (5293) : 1652-1659
65． Kluck RM, Bossy-Wetzel E. Green DR, et al. The release of cytochrome C from mitochondria: A primary Site for Bcl-2 regulation of apoptosis[J]. Science. 1997, 275(21) : 1132-1136
66． Krupp J J, et al. Interactions of calmodulin and a-actinin with the NR1 subunit modulate Ca2+-dependent inactivation of NMDA receptors[J]. J Neurosci. 1999,19: 1165-1172
67． Kuchler S, Zanetta JP. Mannose dependent tightening of the rat ependymal cell barrier. In vivo and in vitro study using neoglycoproteins[J]. Neurochem Int. 1994, 24(1) : 43-55
68． Lanzrein AS, Sim E. Mannan-binding lectin in human serum, cerebrospinal fluid and brain tissue and its role in Alzheimer's disease[J]. Neuroreport. 1998, 9(7) : 1491-1495
69． Le Blanc A, et al. Caspase-6 Role in Apoptosis of Human Neurons, Amyloid-ogenesis. and Alzheimer's Disease[J]. J Biol Chem. 1999,274:23426-23436
70． Leuba G, Kraftsik R . Visual cortex in Alzheimer's disease: occurrence of neuronal death and glial proliferation, and correlation with pathological hallmarks. Neurobiol Aging. 1994, 15(1) : 29-43
71． Lin, A. W., M. Barradas, et al. Premature senescence involving p53 and p16 is activated in response to constitutive MEK/MAPK mitogenic signaling[J]. Genes. 1998, 12: 3008-3019
72． Lippa CF, Nee LE, et al. Aβ42 deposition precedes other changes in PS-1 Alzheimer' s disease[J]. Lancet. 1998, 352: 1117-1118
73． Liu J, Tong Y K, Liu H, et at. Effect of P15INK4b expression on the cell cycle and Gl phase related regulatory gene in human melanoma cells [J]. Progress in Natural Science. 2001; 11(1) : 40-45
74． Loring JF; Wen X; Fuhrman S; Seilhamer J. Use of gene expression microarrays to MAP molecular pathology in Alzheimer disease brain. Society for Neuroscience . 2000． 26(1-2) :833-835
75． Loring JF, Wen X, Lee JM, Seilhamer J, Somogyi R. A gene expression profile of Alzheimer's disease. DNA Cell Biol. 2001,20(11) :683-695
76． Lukiw WJ, McLachlan DR. Cytoskeletal messenger RNA stability in human neocortex: studies in normal aging and in Alzheimer's disease[J]. Int J Neurosci. 1990, 55(2-4) :81-88
77． Mackler JM, Reist NE. The C(2) B Ca(2+)-binding motif of synaptotagmin is required for synaptic transmission in vivo[J]. Nature. 2002, 418(6895) : 340-344
78． Magavi SS, Leavitt BE, et al. Nature.2000,405:892( 刘璇等 ,2003 引用 )
79． Marcos Malumbres, Ignacio Perez, et al. Cellular Response to Oncogenic Ras Involves Induction of the Cdk4 and Cdk6 Inhibitor p15INK4b [J]. Molecularand Cellular Biology. 2000, 20(8) : 2915-2925
80． Markus EJ. Petit TL. Synaptic structural plasticity: Role of synaptic shape[J]. Synapse. 1989,3: 1-11
81． Matsumoto A, Seki Y, et al.Suppression of STAT5 functions in liver, mammary glands, and T cells in cytokine-inducible SH2-containing protein 1 transgenic mice. Mol Cell Biol[J]. 1999, 19(9) :6396-6407
82． McGeer P. L, Rogers J. et al. Neuroimmune mechanisms in Alzheimer disease pathogenesis. [J] Alzheimer Disease and Associated Disorders[J]. 1994,8:149-165
83． McKee AC; Follettie M T. Gene expression profiling in Alzheimer's disease brain by DNA microarrays .Society for Neuroscience. 2000,26(1-2) : 839-846
84． McShea A, Harris PL, Webster KR et al. Abnormal expression of the cell cycle regula-tors p16 and CDK4 in Alzheimer's disease[J]. Am J Pathol, 1997, 150(6) : 1933-1939
85． Meier-Ruge W, Iwangoff P, et al. What is primary and what secondary for amyloid disposition in Alzheimer's disease [J]. Ann NY Acad Sci. 1994, 719:230-235
86． Meltzer CC, Smith G, DeKosky ST, et al. Serotomin in Aging, Late-Life Depression, and Alzheimer's Disease: The Emerging Role of Functional Imging [J]. Neuropsy-cho pharmacology. 1998, 18:407-430
87． Morrison J, Hof P. Life and death of neurons in the aging brain [J]. Science. 1997,278: 412-419
88． Mori K, Ogawa Yet al.Kidney-specific expression of a novel mouse organic cation transporter-like protein [J]. FEBS Lett. 1997, 417(3) :371-374
89． Mufson EJ; Ginsberg S D. Expression profile of cholinergic basal forebrain neurons in
mild Alzheimer's disease using gene microarrays. Society for Neuroscience. 2000, 26(1-2) :835-842
90． Mufson EJ; Ginsberg S D . Single cell and regional cDNA microarray analysis of cholinergic basal forebrain neurons in aged and Alzheimer's disease brain. Society for Neuroscience. 2001,27(1) :253-261
91． Mukaetova-Ladinska EB, Harrington CR,et al.Alterations in tau protein metabolism during normal aging [J]. Dementia 1996, 7(2) :95-103
92． Nagy ZS, Esiri MM. Apoptosis-related protein expression in the hippocampus in Alzheimer's disease. Neurobiol Aging. 1998,18:565-571
93． Nayak AS, Moore CI, et al.Ca2+/calmodulin-dependent protein kinase Ⅱ phosphorylation of the presynaptic protein synapsin I is persistently increased during long-term potentiation [J]. Proc Natl Acad Sci USA. 1996, 93(26) : 15451-15456
94． Nelson JS. Alzheimer athology in elderly patients with glioblastoma multiforme [J]. Arch Pathol Lab Med. 2002, 126(12) :1515-1517
95． Nishimura M, Namba Y, et al. Glial fibrillary tangles with straight tubules in the brains of paitients with progressive supranuclear palsy [J]. Neurosci Lett. 1992,143:35-38
96． Ono T, Yamamoto H,et al. Dephosphorylation of abnormal sites of tau factor by protein phosphatases and its implication for Alzheimer's disease [J]. Neurochem Int 1995 , 26(3) : 205-215
97． Palacios G, Mengod G, et al. Increased beta-amyloid precursor protein expression in astrocytes in the gerbil hippocampus following ischaemia: association with proliferation of astrocytes[J]. Eur J Neurosci. 1995, 7(3) : 501-510
98． Pasinetti GM, Ho L. From cDNA microarrays to high-throughput proteomics. Implications in the search for preventive initiatives to slow the clinical progression of Alzheimer's disease dementia.Restor Neurol Neurosci,2001,18(2-3) :137-142 a
99． Pasinetti GM. Use of cDNA microarray in the search for molecular markers involved in the onset of Alzheimer's disease dementia. J Neurosci Res. 2001,65(6) : 471-476 b
100． Petersen RC, Smith GE, et al. Mild cognitive impairment: clinical characterization and outcome[J]. Arch Neurol, 1999, 56: 303-308
101． Pezet A, Favre H, et al.Inhibition and restoration of prolactin signal transduction by suppressors of cytokine signaling[J]. J Biol Chem . 1999 , 274(35) : 24497-24502
102． Pluta R, Misicka A, Nidan RU, et al. Transport of human beta-amyloid peptide through the rat blood brain barrier after global cerebral ischemia[J]. Acta Neurochir, 1997, 70 (suppl): 247-249
103． Prinjha R, Moore SE, et al. Inhibitor of neurite outgrowth in humans[J]. Nature. 2000, 403: 383-384
104． Reddy PH; Teng S; Yu P. Differential expression of genes in Alzheimer's disease using cDNA microarrays. Society for Neuroscience. 2000,26 (1-2) : 834-840
105． Rogers J. Cooper N R. et al. Compliment activation by p-amyloid in Alzheimer's disease[J]. Proceedings of the National Academy of Science. U.S.A. 1992,89:1016-1020
106． Rosehl T W, Gappert M, et al. Short-term synaptic plasticity is lacking in mice lacking synapsin I [J]. Cell. 1993, 75(4) : €61-676
107． Rumny NJ. The aging eye and vision appliances [J]. Ophthalmid and Physiology Optics. 1998, 18: 191-196
108． Sadowski CL, Wheeler TT, et al. GH regulation of IGF-I and suppressor of cytokine signaling gene expression in C2C12 skeletal muscle cells[J]. Endocrinology. 2001 S. 142 (9) : 3890-3900
109． Saegusa M, Machida B D, et al.Possible associations among expression of p!4(ARF). p16(INK4a), p21(WAFl/CIPl),p27(KIPl), and p53 accumulation and the balance of apoptosis and cell proliferation in ovarian carcinomas[J]. Cancer. 2001, 92(5) : 1177-1189
110． Satou T, Cummings BJ, Head E, Cotman CW.et al. The progression of beta-amyloid deposition in the frontal cortex of the aged canine[J]. Brain Res. 1997,774(l-2) :35-43
111 .Scheuner D, Eckman C, et al. Secreted amyloid beta-protein similar to that the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease[J]. Nat Med. 1996,15: 2864-2870
112． Sengupta A, Kabat J, et al. Phosphorylation of tar at both Thr 231 and Ser 262 is required for maximal inhibition of its binding to microtubules[J]. Arch Biochem Biophys. 1998, 357: 299-309
113． Sennvik, Benedikz E, Fastbom E, et al. Calcium ionophore A23187 specifically decreases the secretion of beta-secretase cleaves amyloid precursor protein during apoptosie in primary rat cortical cultures[J]. J Neurosci Res. 2001, 63: 429-437
114． Sergeant N, David JP,et al.Two-dimensional characterization of paired helical filament-tau from Alzheimer's disease: demonstration of an additional 74-kDa component and age-related biochemical modifications [J]. J Neurochem. 1997 , 69(2) : 834-844
115． Shoemaker D D, Lash kari D A, et al. Quantitative phenotypic analysis of years deletion mutants using a highly parallel molecular bar coding strategy[J]. J Nat genet. 1996, 14: 450-456
116． Sironi J J, Yen S H, et al. Ser-262 in human recombinant tau protein is a markedly more favorable site for phosphorylation CaMK II than PKA or PhK [J]. FEBS Lett. 1998, 336: 417-475
117． Sontag E, Nunbhakdi-Craig V, et al. Molecular interactions among protein phosphatase 2A, tau, and microtubules. Implications for the regulation of tau phosphorylation and the development of tauopathies [J]. J Biol Chem. 1999, 274(36) : 25490-25498
118． Spence J, Finley D. Cell cycle-regulated modification of the ribosome by a variant multiubiquitin chain[J]. Cell. 2000, 102( 1) : 67-76．
119． Sze CI, Bi H, leinschmidt-DeMasters BK, et al. Selective regional loss of exocytotic presynaptic vesicle proteins in Alzheimer's disease brains [J]. J Neurol Sci. 2000, 175 (2) : 81-90
120． Tagami S, Eguchi Y,et al.A novel protein, RTN-XS, interacts with both Bel-XL and Bcl-2 on endoplasmic reticulum and reduces their anti-apoptotic activity [J]. Oncogene. 2000, 19(50) : 5736-5746
121． Takahashi J, Paimer T D, et al. Retinoic acid and neurocrophins collaborate to regulate neurogenesis in adule-derived neural stem cell cultures [J]. J Neurobiology. 1999, 38 (1) : 65-81
122． Takeda T, Hosokawa M, Higuchi K. Senescence-Accelerated Mouse(SAM): A novel murine model of accelerated senescence [J]. Geriatric Bioscience. 1991, 39(9) : 911-919
123． Takeda T, Hosokawa M, Higuchi K, Hosono M, Akiguchi I, Katoh H. A novel murine model of aging; Senescence-Accelerated-Mouse[J]. Arch Gerontol Geriatr. 1994,19: 185-192
124． Takeda T, Matsushita T, Kurozumi M, Takemura K, Higuchi K, Hosokawa M. Pathobiology of the Senescence Accelerated Mouse (SAM) [J]. Exp Gerontol. 1997, 32: 117-127
125． Tong Y K, Liu H. p15--a new turner suppressor gene [J]. Chinese Science Bulletin. 1999, 44(13) :1157-1163
126． Tucker WC, Chapman ER. Role of synaptotagmin in Ca2+-triggered exocytosis[J]. Biochem J. 2002, 15 (366) : 1-13．
127． Van Gool D, Carmeliet G,et al.Appearance of localized immunoreactivity for the alpha 4 integrin subunit and for fibronectin in brains from Alzheimer's, Lewy body dementia patients and aged controlsfJ]. Neurosci Lett. 1994, 170(1) :71-73
128． Vossoughi J, Vaishnav RN.Comments on the paper "Volume Compressibility of Human Abdominal Skin"[J]. J Biomech. 1979, 12(6) : 481-489
129． Vogt BA, Vogt LJ, Van Hoesen GW. et al. Multivariate analysis of laminar patterns of neurodegeneration in posterior cingulate cortex in Alzheimer's disease[J]. Exp Neurol 1998,153(l):8-22
130． Vrensen G, Nunes Cardozo. Changes in size and shape of synaptic connection after visual training: An ultrastructural approach of synaptic plasticity [J]. Brain Res. 1981, 218:79-97
131． Yoshimura A, Ohkubo T,et al.A novel cytokine-inducible gene CIS encodes an SH2-containing protein that binds to tyrosine-phosphorylated interleukin 3 and erythropoietin receptors[J]. EMBO J. 1995, 14(12) : 2816-2826
132． Wang J Z, Grundke-Iqbal I, Iqbal K. dephosphorylation of Alzheimer soluble abnormally phosphorylated tau by PP-2A, PP-2B and PP-1[J]. Mol Brain Res.1996, 38: 200-207,
133． Ying W. Deleterious network hypothesis of Alzheimer's disease[J]. Med Hypothesis. 1996,46:421-428
134． Yu Shang Cai, Li Xiao Yu. Alzheimer's of apoptosis[J]. Chin J Neutoinmmunol & Neuro. 1999,6(l):5459-5466
135． Zambrzycka A, Alberghina M, Strosznajder JB. Effects of aging and amyloid-beta peptides on choline acetyltransferase activity in rat brain[J]. Neurochem Res.2002,27(4) :277-281
136． Zhu J, D. Woods, et al. Senescence of human fibroblasts induced by oncogenic Raf. Genes.1998, 12: 2997-3007
137． Z. Nagy, M.M. Esiri. et al. Cell cycle markers in the hippocampus in Alzheimer's disease. Acra Neuropathologica.1997, 94(1) : 6-15
138．Peter Duus 著，刘宗惠，胡威夷等译．神经系统疾病定位诊断学—解剖、生理、临床．北京，海洋出版社，1995．a：224
139．I．B 莱维坦等著，舒斯云等译．神经元：细胞和分子生物学．第一版，北京，科学出版社，2001．a：18：b：140-141；c：88；d：27；e：264；f：155
140．R．J．B．金著，刘以训等译．癌生物学．北京：科学出版社，2002．a：110；b：136
141．蔡大勇，赵雁．D-半乳糖致原代培养神经元损伤模型的研究[J]．中国病理生理杂志．2002，18(7)：794-797
142．车林海，贾建平．老年期痴呆 129 例的临床研究[J]．中风与神经疾病杂志．2002．19(4)：213-215
143．陈俊抛等主编．痴呆治疗学，人民军医出版社，北京，2002．a：19；b：41
144．陈水灿．古代针灸益智临床经验节要[J]．中国针灸．1997，17(5)：312
145．成丽俊．基因芯片技术及其在医学中的应用[J]．国外医学计划生育分册．2001．20(2)：66-71
146．陈可冀主编．新编抗衰老中药学．北京：人民卫生出版社．1998：153
147．陈可冀主编．跨世纪脑科学·老年痴呆发病理与诊治．北京医科大学、中国协和医科大学联合出版社．1998：309
148．崔天益，周新等．载脂蛋白 E 基因多态性与散发性老年性痴呆病的关系[J]．中国病理生理杂志．2000，16(8)：741-743 a
149．崔天益，周新等．早衰蛋白-1 基因内含子多态性与 Alzheimer's 病的关系[J]．基础医学与临床．2000，20(4)：21-23 b
150．崔云华．细胞外基质与细胞周期调控[J]．国外医学分子生物学分册．2002，24(1)：47-49
151．董洪涛．金渊光等．针刺治疗老年性痴呆 11 例[J]．上海中医药大学学报．2002，16(3)：26-28
152．董洪涛，房縏恭．多因素 AD 动物模型的建立及针刺对其学习记忆功能的影晌[J]．上海中医药杂志．2002，5：43-46
153．杜红燕，张维宁等．两组不同月龄小鼠学习记忆能力与脑突触体内游离[Ca~(2+)]i 的相关性[J]．生理学报．1996，48：43-47
154．冯方俊，涂晋文．寿尔智胶囊对老年性痴呆模型鼠海马神经元 c-fos、[Ca~(2+)]i 的影响[J]．湖北中医学院学报．2002，4(3)：16-18 a．
155．冯方俊，涂晋文．寿尔智胶囊对衰老模型鼠行为学影响的实验研究[J]．湖北中医杂］志．2002，24(7)：3-4 b．
156．付东红．我校童坦君、张宗玉教授发现 P16 基因的作用机理．www.pku.edu.cn/news/xiao_kan/news/203/03-05.htm
157．高静，等．行为训练与小鼠海马突触蛋白的磷酸化水平的相关性[J]．生理学报．1992，44(1)：86-91
158．高希言，关晨霞．针灸督脉经穴对小鼠学习记忆和胆碱酯酶活性的影响[J]．国医论坛．2001，16(2)：55-56
159．顾智磊：吴政红等．ApoE 基因型多态性与老年性痴呆的相关性．上海第二医科大学学报．2001．21(4)：325-327
160．韩杰，王琳等．阿尔兹海默病不同阶段的临床神经心理学研究[J]．中国神经精神疾病杂志．2002，28(1)：45-46
161．韩济生主编．神经科学原理．第二版，北京，北京医科大学出版社，2001．a：988；b：536；c：997；d：394；e：363；f：888-890；g：307；h：409
162．景献．日本快速老化模型小白鼠(SAM)老化诸特征[J]．实验动物与管理．1995，12(4)：21-29
163．胡爱群，王桐．阿尔兹海默病老年斑研究进展[J]．国外医学·老年医学分册．2001．22(2)：74-77
164．胡海峰，朱宝泉．乙酰胆碱酯酶及其抑制剂的研究进展．国外医药抗生素分册．1999，20(2)：81-87
165．冀成君，金弘敏．痴呆病人 ApoE 基因检测与多态性分析[J]．现代康复．2000，4(10)：1524-1525
166．贾建平、贾健民等．阿尔兹海默病和血管性痴呆患者脑脊液中乙酰胆碱和胆碱检测及其临床意义[J]．中华神经科杂志．2002，35(3)：168-170
167．姜国华，魏群科技时报钙调神经磷酸酶 B 亚基的~(125)Ⅰ标记及其血脑屏障的通透性[J]．同位素．2001，8(3-4)：201-205
168．科学时报．老而不衰基因定夺．www.cas.ac.cn/html/Dir/2003/02/12/7022.htm
169．李亚．秦海强等．β-淀粉样蛋白对D-半乳糖致衰大鼠行为及海马 SOD 活性和 MDA 含量的影响[J]．中国病理生理杂志．2001，17(1)：16-18
170．刘昌．李德明．大脑老化研究及其进展[J]．自然杂志．1996，18(5)：286-290
171．刘长春．文孟良．生物芯片[J]．分析仪器．2001，3：37-39
172．刘强．杨琳．大鼠心脏与内关穴区神经投射同源关系的非荧光双标记示踪[J]．解部学杂志．2002．25(1)：39-41
173．刘庆忠，郑灏泳．针刺对快速老化痴呆模型小白鼠红细胞变形能力影响的实验研究[J]．中国针灸．2001，21(5)：309-310
174．刘薇，卢光秀．阿尔茨海默病相关 PDAPSW 转基因小鼠模型的表型研究[J]．中华神经科杂志．2002，35(4)：201-203
175．刘勇林，李晨旭等．脑内一氧化氮对大鼠学习功能的影响[J]．北京医科大学学报．1996，28：306
176．刘一凡，石学敏．针刺对快速老化脑萎缩模型小鼠脑抗氧化酶活性的影响[J]．中国针灸．2002，22(5)：327-330
177．刘璇，林万敏等．成年神经干细胞研究现状．细胞生物学杂志．2003，25(1)：1-5
178．裴印权，苏丹．NMAD 受体和其拮抗剂的药理[J]．中国药理学通报．1996，12：303-306
179．钱卓．脑功能基因组学的研究．CETV口：学术报告厅．2003-1-29(10：45PM)
180．司徒镇强，吴军正主编．细胞培养[M]．第1版．西安世界图书出版公司出版．1999，121-124，181-210
181．瞿正万，顾立铭．老年期痴呆忠者脑室脑沟扩大与认知障碍的相关性分析[J]．心理科学．1999，22：373-374，370
182．盛建华，高之旭等．轻至中度阿尔茨海默病患者认知和生活功能的自然演变[J]．中国神经精神疾病杂志．2002，28(1)：30-32
183．盛树力．老年性痴呆：从分子生物学到临床诊治．北京：科学技术文献出版社．1999，351-355
184．石学敏，韩景献等．针刺对老化痴呆鼠脑兴奋性氨基酸水平影响的实验研究[J]．中国针灸．1998，11：689-692，793
185．王德生，张守信主编．老年性痴呆．第一版，北京，人民卫生出版社，2001．a：373；b：97-161；c：153-156；d：229；e：181c f：65-69；h：218
186．王哲，周昌玉 Hp 感染与老年胃癌及癌前病变中 bcl-2、p16、c-myc 基因表达的关系[J]．中国老年学杂志．2002，7(22)：264-266
187．王升启．基因芯片技术及应用研究进展[J]．生物工程进展．1999，19(4)：45-50
188．汪义朋，王群．阿尔茨海默病患者神经细丝 mRNA 含量及突变的检测[J]．中华医学杂志．2002，82(8)：519-522
189．王振龙．醒脑开窍加体针治疗老年性痴呆[J]．针灸临床杂志．1997，13(9)：16
190．魏小龙，张永祥．老年性痴呆动物模型研究进展．中国药理学通报．2000，16(4)：372-376
191．温廷益，韩景献．针刺对快速老化鼠脑、肝细胞核活性基因的影响[J]．中医杂［
志，2002，43(1)：28-29
192．吴馥梅，杜红燕等．突触界面曲率及其生理意义[J]．神经解剖学杂志，1994，10：89-92
193．吴馥梅，肖信生．神经肽与学习记忆．姚志彬等主编．脑研究前沿，广东科技出版社，1995：268-290
194．吴哲，孙黎光等．穹窿海马伞切断大鼠海马 PKC 和 ERK 活性的变化[J]．中风与神经疾病杂志．2002，19(4)：216-219
195．夏保芦，程标．电针“内关”穴抗过敏性休克作用与脑内催产素含量的关系[J]．针刺研究．2001，26(1)：10-14
196．项志清，陈月敏等．阿尔兹海默病的扩瞳试验研究[J]．中华精神科杂志．2001，34(1)：1-3
197．谢建军，胡亚美．泛素-蛋白酶体途径恶性肿瘤、关系的研究进展[J]．中国癌症杂志．2002，12：74-76
198．徐敏．载脂蛋白 E 与老年痴呆研究新进展[J]．现代康复．2001，5(8A)：60-61
199．徐天乐．神经元钙信号的分子机制[J]．申经解剖学杂志．1998，14：195
200．许绍芬主编．神经生物学．第二版，上海，上海医科大学出版社，1999．a：58；b：10-15；c：477-480；d：74
201．严振国主编．中医应用腧穴解剖学．上海中医药大学出版社，2001，P50，23，102，105
202．杨增瑞，来丽萍等．针刺对快速老化痴呆模型小白鼠脑内ACH含量及ACHE活性影响的实验研究[J]．天津中医．1999，16(3)：20-21
203．曾湘豫，秦斌．脑脊液 Aβ42 和 tau 蛋白的联合测定——有望成为 Alzheimer 病早期诊断的生物学参数[J]．中国神经免疫学和神经病学杂志．2002，9(1)：39-41
204．章静波，林建银等．医学分子细胞生物学．中国协和医科大学出版社，2002．a：91；b：323
205．张转．GSTs 与肿瘤及其化疗耐药之间的关系[J]．肿瘤防治研究．2000，27(6)：498．501
206．张春红，王舒．针刺对局灶性脑缺血大鼠脑细胞凋亡的影响[J]．针刺研究．2001，26(2)：102-105
207．张林杰．微阵列技术及其应用[J]．国外医学分子生物学分册．2001，23(1)：46-48
208．周乐全，张晓东等．补肾益智方对痴呆模型大鼠学习记忆能力的影响[J]．中医研究．2001，14(2)：23-25
209．朱粹青，曹小定．蛋白磷酸酶(PP)-1和-2A抑制剂对 NG108-15 细胞 tau 蛋白磷酸化的影响[J]．细胞生物学杂志．2002，24(2)：115-117
210．朱长庚主编．神经解剖学．第一版，北京，人民卫生出版社．2002．a：235-246；b：529-533；c：502；d：506；e：472；f：479